Immunocore

Results: 5



#Item
1PRESS RELEASE – IMMUNOCORE LIMITED Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma (Oxford, UK, 30 MarchImmunocore, a world-leading biotechnology company developing novel T cell

PRESS RELEASE – IMMUNOCORE LIMITED Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma (Oxford, UK, 30 MarchImmunocore, a world-leading biotechnology company developing novel T cell

Add to Reading List

Source URL: www.immunocore.com

Language: English - Date: 2016-03-29 05:35:06
2PRESS RELEASE – IMMUNOCORE LIMITED Immunocore’s ImmTAV shown to redirect the immune system to kill HIVinfected cells from patients treated with antiretroviral therapy - -

PRESS RELEASE – IMMUNOCORE LIMITED Immunocore’s ImmTAV shown to redirect the immune system to kill HIVinfected cells from patients treated with antiretroviral therapy - -

Add to Reading List

Source URL: www.immunocore.com

Language: English - Date: 2016-06-10 10:46:57
3PRESS RELEASE – IMMUNOCORE LIMITED Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting -

PRESS RELEASE – IMMUNOCORE LIMITED Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting -

Add to Reading List

Source URL: www.immunocore.com

Language: English - Date: 2016-06-06 05:18:35
4PRESS RELEASE – IMMUNOCORE LIMITED Immunocore named one of Fierce 15 leading biotechs of[removed]Oxford, UK, 24 September[removed]Immunocore Limited, the Oxford-based biotechnology company developing novel biological drug

PRESS RELEASE – IMMUNOCORE LIMITED Immunocore named one of Fierce 15 leading biotechs of[removed]Oxford, UK, 24 September[removed]Immunocore Limited, the Oxford-based biotechnology company developing novel biological drug

Add to Reading List

Source URL: www.immunocore.com

Language: English - Date: 2013-09-24 03:45:28
5ImmTAC Technology Overview Introducing the Technology The challenge for any immunotherapeutic strategy is to effectively target and eradicate diseased cells. Over recent years, antibodies in various guises have provided

ImmTAC Technology Overview Introducing the Technology The challenge for any immunotherapeutic strategy is to effectively target and eradicate diseased cells. Over recent years, antibodies in various guises have provided

Add to Reading List

Source URL: www.immunocore.com

Language: English - Date: 2013-06-25 14:43:22